viimane versioon :
19/11/2024
Antimuskarinergiline ravim   Glycopyrronium bromide  
suukaudne lahus
Süsteravim
Stabiilsust ravimpreparaadid Stabiilsust mõjutavad tegurid stabiilsust mõjutavad faktorid Sobimatus Viited pdf
   keemiline struktuur  

suukaudne lahus
Viited   suukaudne lahus   Viited : Glycopyrronium bromide  
tüüp avaldamine
2833 ajaleht Das Gupta V.
Stability of an Oral Liquid Dosage Form of Glycopyrrolate Prepared from Tablets
Int J Pharm Compound 2001 ; 5, 6: 480-481.
2834 ajaleht Das Gupta V.
Stability of Oral Liquid Dosage Forms of Glycopyrrolate Prepared With the Use of Powder
Int J Pharm Compound 2003 ; 7, 5: 386-388.
3203 ajaleht Cober MP, Johnson CE, Sudekum D, Penprase K
Stability of extemporaneously prepared glycopyrrolate oral suspensions.
Am J Health-Syst Pharm 2011 ; 68:843-845.
3856 ajaleht Nahata M.C.
Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures
Int J Pharm Compound 2016 ; 20, 2:164-166.
4198 ajaleht Uriel M, Gomez-Rincon C, Marro D.
Stability of regularly prescribed oral liquids formulated with SyrSpend® SF.
Pharmazie 2018 73;196-201

  Mentions Légales